Astragaloside IV Relieves Atherosclerosis and Hepatic Steatosis via MAPK/NF-κB Signaling Pathway in LDLR−/− Mice
出版年份 2022 全文链接
标题
Astragaloside IV Relieves Atherosclerosis and Hepatic Steatosis via MAPK/NF-κB Signaling Pathway in LDLR−/− Mice
作者
关键词
-
出版物
Frontiers in Pharmacology
Volume 13, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2022-02-21
DOI
10.3389/fphar.2022.828161
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Astragaloside IV Ameliorates Myocardial Infarction Induced Apoptosis and Restores Cardiac Function
- (2021) Chuang Sun et al. Frontiers in Cell and Developmental Biology
- Early astragaloside IV administration attenuates experimental autoimmune encephalomyelitis in mice by suppressing the maturation and function of dendritic cells
- (2020) Liu Yang et al. LIFE SCIENCES
- Astragaloside IV suppresses inflammatory response via suppression of NF-κB, and MAPK signalling in human bronchial epithelial cells
- (2020) Hsi-Lung Hsieh et al. ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY
- Lipid lowering therapy in cardiovascular disease: From myth to molecular reality
- (2020) Philipp Mourikis et al. PHARMACOLOGY & THERAPEUTICS
- Arteriosclerosis e inflamación. Nuevos enfoques terapéuticos
- (2020) Juan Pedro-Botet et al. MEDICINA CLINICA
- Taoren Honghua Drug Attenuates Atherosclerosis and Plays an Anti-Inflammatory Role in ApoE Knock-Out Mice and RAW264.7 Cells
- (2020) Yiru Wang et al. Frontiers in Pharmacology
- New possible pharmacological targets for statins and ezetimibe
- (2020) Mateusz Niedzielski et al. BIOMEDICINE & PHARMACOTHERAPY
- Astragaloside IV: An Effective Drug for the Treatment of Cardiovascular Diseases
- (2020) Yu-Qing Tan et al. Drug Design Development and Therapy
- Statin Safety and Associated Adverse Events: A Scientific Statement From the American Heart Association
- (2019) Connie B. Newman et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Astragaloside IV Suppresses High Glucose-Induced NLRP3 Inflammasome Activation by Inhibiting TLR4/NF-κB and CaSR
- (2019) Bin Leng et al. MEDIATORS OF INFLAMMATION
- Nicotinamide phosphoribosyltransferase aggravates inflammation and promotes atherosclerosis in ApoE knockout mice
- (2019) Yuan-yuan Kong et al. ACTA PHARMACOLOGICA SINICA
- The Role of Astragaloside IV against Cerebral Ischemia/Reperfusion Injury: Suppression of Apoptosis via Promotion of P62-LC3-Autophagy
- (2019) Yi Zhang et al. MOLECULES
- Modulation of Nitric Oxide Synthases by Oxidized LDLs: Role in Vascular Inflammation and Atherosclerosis Development
- (2019) Micaela Gliozzi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The effect of astragaloside IV on JAK2‐STAT6 signalling pathway in mouse model of ovalbumin‐induced asthma
- (2019) Xinfu Yang et al. JOURNAL OF ANIMAL PHYSIOLOGY AND ANIMAL NUTRITION
- Inhibition of microRNA-103 attenuates inflammation and endoplasmic reticulum stress in atherosclerosis through disrupting the PTEN-mediated MAPK signaling
- (2019) Li Jiang et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Atherosclerosis: Pathophysiology of insulin resistance, hyperglycemia, hyperlipidemia, and inflammation
- (2019) Joshua K. Beverly et al. Journal of Diabetes
- Combination of tanshinone IIA and astragaloside IV attenuate atherosclerotic plaque vulnerability in ApoE(-/-) mice by activating PI3K/AKT signaling and suppressing TRL4/NF-κB signaling
- (2019) Nanding Wang et al. BIOMEDICINE & PHARMACOTHERAPY
- Baicalin alleviates atherosclerosis by relieving oxidative stress and inflammatory responses via inactivating the NF-κB and p38 MAPK signaling pathways
- (2018) Yuliang Wu et al. BIOMEDICINE & PHARMACOTHERAPY
- Astragaloside IV protects against the pathological cardiac hypertrophy in mice
- (2018) Zhen-hu Liu et al. BIOMEDICINE & PHARMACOTHERAPY
- Endothelial microRNAs regulating the NF-κB pathway and cell adhesion molecules during inflammation
- (2018) Liang Zhong et al. FASEB JOURNAL
- Astragaloside IV Inhibits Cigarette Smoke-Induced Pulmonary Inflammation in Mice
- (2018) Zhou Meiqian et al. INFLAMMATION
- LOX-1 receptor: A potential link in atherosclerosis and cancer
- (2018) Silvana Balzan et al. LIFE SCIENCES
- Beneficial effects of naringenin in liver diseases: Molecular mechanisms
- (2018) Erika Hernández-Aquino et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Impact of Lipids on Cardiovascular Health
- (2018) Brian A. Ference et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Foam cell formation: A new target for fighting atherosclerosis and cardiovascular disease
- (2018) Eithne M. Maguire et al. VASCULAR PHARMACOLOGY
- Astragaloside Ⅳ combating liver cirrhosis through the PI3K/Akt/mTOR signaling pathway
- (2018) Rendong Wei et al. Experimental and Therapeutic Medicine
- Renoprotective mechanisms of Astragaloside IV in cisplatin-induced acute kidney injury
- (2017) Wei Yan et al. FREE RADICAL RESEARCH
- Anti-inflammatory and immunomodulatory mechanisms of atorvastatin in a murine model of traumatic brain injury
- (2017) Xin Xu et al. Journal of Neuroinflammation
- Global, Regional, and National Burden of Cardiovascular Diseases for 10 Causes, 1990 to 2015
- (2017) Gregory A. Roth et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Astragaloside IV attenuates cognitive impairments induced by transient cerebral ischemia and reperfusion in mice via anti-inflammatory mechanisms
- (2017) Min Li et al. NEUROSCIENCE LETTERS
- Cavin-1 regulates caveolae-mediated LDL transcytosis: crosstalk in an AMPK/eNOS/ NF-κB/Sp1 loop
- (2017) Xiang-Li Bai et al. Oncotarget
- Inflammation in atherosclerosis
- (2016) Soraya Taleb Archives of Cardiovascular Diseases
- Epidemiology of Atherosclerosis and the Potential to Reduce the Global Burden of Atherothrombotic Disease
- (2016) William Herrington et al. CIRCULATION RESEARCH
- Recent Insights Into the Relationship Between Inflammatory Liver Diseases and Atherosclerosis
- (2016) Tugrul Purnak et al. JOURNAL OF INVESTIGATIVE MEDICINE
- Adverse Effects of Statins - Myths and Reality
- (2015) Iveta Simic et al. CURRENT PHARMACEUTICAL DESIGN
- Effects of Astragaloside IV on the SDF-1/CXCR4 Expression in Atherosclerosis of apoE−/−Mice Induced by Hyperlipaemia
- (2015) Hewei Qin et al. Evidence-based Complementary and Alternative Medicine
- Recent insights into the cellular biology of atherosclerosis
- (2015) Ira Tabas et al. JOURNAL OF CELL BIOLOGY
- Astragaloside IV Inhibits NF-κB Activation and Inflammatory Gene Expression in LPS-Treated Mice
- (2015) Wei-Jian Zhang et al. MEDIATORS OF INFLAMMATION
- Statins stimulate atherosclerosis and heart failure: pharmacological mechanisms
- (2015) Harumi Okuyama et al. Expert Review of Clinical Pharmacology
- Hepatocyte free cholesterol lipotoxicity results from JNK1-mediated mitochondrial injury and is HMGB1 and TLR4-dependent
- (2014) Lay T. Gan et al. JOURNAL OF HEPATOLOGY
- Extracts from Astragalus membranaceus limit myocardial cell death and improve cardiac function in a rat model of myocardial ischemia
- (2013) Xu Ma et al. JOURNAL OF ETHNOPHARMACOLOGY
- β-Glucan attenuates inflammatory responses in oxidized LDL-induced THP-1 cells via the p38 MAPK pathway
- (2013) S. Wang et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- Molecular Biology of Atherosclerosis
- (2013) Paul N. Hopkins PHYSIOLOGICAL REVIEWS
- Dual role of lipoproteins in endothelial cell dysfunction in atherosclerosis
- (2012) Camelia S. Stancu et al. CELL AND TISSUE RESEARCH
- Astragaloside IV, a Novel Antioxidant, Prevents Glucose-Induced Podocyte Apoptosis In Vitro and In Vivo
- (2012) Dingkun Gui et al. PLoS One
- Prevalence of non-alcoholic fatty liver disease and its association with cardiovascular disease in patients with type 1 diabetes
- (2010) Giovanni Targher et al. JOURNAL OF HEPATOLOGY
- Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease
- (2010) Giovanni Targher et al. NEW ENGLAND JOURNAL OF MEDICINE
- Decreased survival of subjects with elevated liver function tests during a 28-year follow-up
- (2009) Cecilia Söderberg et al. HEPATOLOGY
- The Pathology of Atherosclerosis: Plaque Development and Plaque Responses to Medical Treatment
- (2008) William Insull AMERICAN JOURNAL OF MEDICINE
- Elevated alanine aminotransferase levels predict mortality from cardiovascular disease and diabetes in Koreans
- (2008) Kyung Eun Yun et al. ATHEROSCLEROSIS
- Increased risk of cardiovascular disease in non-alcoholic fatty liver disease: causal effect or epiphenomenon?
- (2008) G. Targher et al. DIABETOLOGIA
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started